Joel Dudley is a physician-scientist turned venture investor who brings hands-on experience building precision medicine infrastructure at Mount Sinai and Tempus to his role as biotech partner at Innovation Endeavors. He focuses on backing companies that treat biology as an engineering problem and applies AI to specific regulatory bottlenecks in drug development, such as his investment in Weave Bio for automating regulatory document processes. Joel Dudley is a physician-scientist turned venture investor who brings hands-on experience building precision medicine infrastructure at Mount Sinai and Tempus to his role as biotech partner at Innovation Endeavors. He focuses on backing companies that treat biology as an engineering problem and applies AI to specific regulatory bottlenecks in drug development, such as his investment in Weave Bio for automating regulatory document processes.